Tocagen
San Diego
About Tocagen
Tocagen is a biopharmaceutical company, engages in the discovery, development, and commercialization of products for the treatment of cancer. It develops gene therapy products for treating primary tumors and metastatic diseases. The company's products comprise Prodrug Activator product candidates for treating glioblastoma multiforme; and immunotherapeutic product candidates for treating metastatic malignant melanoma. Tocagen was founded in 2007 and is based in San Diego, California.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $198.4M
- Funding stage: M&A
- Last round: Post-IPO Equity (Dec 2018)
- Ticker: nasdaq:TOCA
- Website: tocagen.com
- Phone: 8584128499
Industries & Categories
Biopharma, Biotechnology, Genetics, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/tocagen-177901 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.